The Reimbursement Committee’s recommendation on the future reimbursement status of glucosamine-containing medicines was open for consultation until 8 August 2011.
The Danish Medicines Agency received 4 consultation responses. The box to the right contains links to the consultation responses (in Danish only) and the Danish Medicines Agency’s announcement of 27 May 2011, where you can also find the Reimbursement Committee’s recommendation.
The Reimbursement Committee discussed the consultation responses at its meeting on 23 August 2011 and found no basis to change its recommendation.
The Danish Medicines Agency now deliberates to reach a decision.